Indo Borax & Chemicals Limited — Investor Meet, 01-09-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Indo Borax & Chemicals reported a strong Q1 FY27. Revenue grew to Rs 70.36 Cr (+31.34% YoY), EBITDA to Rs 19.80 Cr (+62.16% YoY) with a 28.14% margin, and PAT to Rs 16.25 Cr (+59.31% YoY), translating to EPS of Rs 5.07. This performance was driven by improved capacity utilization, higher realizations, and steady domestic demand.

Management is optimistic about strategic expansion. The Board approved amalgamating its infra subsidiary and acquiring 64.26% of Kronox Lab Sciences for Rs 246.12 Cr, with an open offer for an additional 25.79%. This move aims for diversification, export reach, and margin enhancement, reinforcing management's confidence in sustainable growth.